On September 6, CDC issued a press release on the outbreak of lung disease associated with using e-cigarette products.
Initial findings from the investigation into serious lung illnesses associated with e-cigarette products point to clinical similarities among those affected. Patients report similar exposures, symptoms and clinical findings and these align with the CDC health advisory released last week. While many of the patients, but not all, reported recent use of THC-containing products, some reported using both THC- and nicotine-containing products. A smaller group reported using nicotine only.
No evidence of infectious diseases has been identified in these patients, therefore lung illnesses are likely associated with a chemical exposure. However, it is too early to pinpoint a single product or substance common to all cases, according to authors of articles published today in CDC’s Morbidity and Mortality Weekly Report (MMWR) and the New England Journal of Medicine.
In addition, CDC hosted a media telebriefing on September 6. A transcript and audio of the telebriefing will soon be available at https://www.cdc.gov/media/.
Stay up to date with CDC’s web page dedicated to the response and general website on e-cigarettes.
Severe Pulmonary Disease Associated with Electronic Cigarette Product Use Interim Guidance
Outbreak of Electronic Cigarette Associated Acute Lipoid Pneumonia
CDC/Office on Smoking and Health